Sort by
Refine Your Search
-
University faculty in professional and career development, teaching, service, and scholarly activities. In partnership with Northeastern University, Zevra Therapeutics is offering a two-year Global Medical
-
University faculty in professional and career development, teaching, service, and scholarly activities. In partnership with Northeastern University, Alnylam Pharmaceuticals is offering a two-year Clinical
-
University faculty in professional and career development, teaching, service, and scholarly activities. In partnership with Northeastern University, Ironwood Pharmaceuticals is offering a two-year Regulatory
-
Northeastern University faculty in professional and career development, teaching, service, and scholarly activities. In partnership with Northeastern University, Apellis Pharmaceuticals is offering a two-year
-
to prepare Fellows to meet the ongoing workforce needs in various areas of industry. Our program gives fellows an opportunity to work with our innovative biopharmaceutical industry partners while collaborating
-
University faculty in professional and career development, teaching, service, and scholarly activities. In partnership with Northeastern University, Abbott Diabetes Care is offering a two-year Global Medical
-
assessment, social drivers of health, and structural barriers and facilitators of diversifying academic health sciences. The fellow will have opportunities to develop and execute their own projects
-
Northeastern University faculty in professional and career development, teaching, service, and scholarly activities. In partnership with Northeastern University, Apellis Pharmaceuticals is offering a two-year
-
University faculty in professional and career development, teaching, service, and scholarly activities. In partnership with Northeastern University, Eidos, a BridgeBio Pharma, Inc. Affiliate, is offering a two
-
with Northeastern University faculty in professional and career development, teaching, service, and scholarly activities. In partnership with Northeastern University, Alnylam Pharmaceuticals is offering